Kazuo Sugimoto

657 total citations
34 papers, 340 citations indexed

About

Kazuo Sugimoto is a scholar working on Neurology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Kazuo Sugimoto has authored 34 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 7 papers in Pathology and Forensic Medicine and 7 papers in Neurology. Recurrent topics in Kazuo Sugimoto's work include Amyotrophic Lateral Sclerosis Research (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Multiple Sclerosis Research Studies (6 papers). Kazuo Sugimoto is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Multiple Sclerosis Research Studies (6 papers). Kazuo Sugimoto collaborates with scholars based in China, Japan and Austria. Kazuo Sugimoto's co-authors include Masahiro Mori, Ying Gao, Satoshi Kuwabara, Jielin Zhang, Yongxiu Liu, Takaki Hiwasa, Akiyuki Uzawa, Hiroki Masuda, Jia Liu and Yiming Zhang and has published in prestigious journals such as Applied Catalysis B: Environmental, Journal of Neurology Neurosurgery & Psychiatry and The Journal of Pediatrics.

In The Last Decade

Kazuo Sugimoto

31 papers receiving 330 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kazuo Sugimoto 105 89 63 46 43 34 340
Ruxiang Xu 159 1.5× 44 0.5× 36 0.6× 35 0.8× 29 0.7× 18 346
Adrian Bălașa 162 1.5× 95 1.1× 36 0.6× 48 1.0× 35 0.8× 42 423
Chong-Un Cheong 130 1.2× 94 1.1× 36 0.6× 71 1.5× 17 0.4× 7 387
Fang Cui 132 1.3× 68 0.8× 28 0.4× 12 0.3× 32 0.7× 46 352
Suning Ping 131 1.2× 42 0.5× 31 0.5× 54 1.2× 16 0.4× 15 321
Makoto Hayase 153 1.5× 69 0.8× 25 0.4× 99 2.2× 56 1.3× 31 429
Hsu‐Tung Lee 131 1.2× 88 1.0× 78 1.2× 48 1.0× 53 1.2× 30 466
Jishu Xian 184 1.8× 80 0.9× 32 0.5× 71 1.5× 57 1.3× 29 384

Countries citing papers authored by Kazuo Sugimoto

Since Specialization
Citations

This map shows the geographic impact of Kazuo Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Sugimoto more than expected).

Fields of papers citing papers by Kazuo Sugimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuo Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Sugimoto. The network helps show where Kazuo Sugimoto may publish in the future.

Co-authorship network of co-authors of Kazuo Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuo Sugimoto. A scholar is included among the top collaborators of Kazuo Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuo Sugimoto. Kazuo Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Yong, Dazhi Jiang, Shunyu Yao, et al.. (2025). Gene-modified animal models of Parkinson's disease. Experimental Neurology. 390. 115287–115287. 1 indexed citations
2.
3.
Sugimoto, Kazuo, et al.. (2024). Zhi‐zi‐chi decoction mitigates depression by enhancing lncRNA Six3os1 expression and promoting histone H3K4 methylation at the BDNF promoter. Journal of Cellular and Molecular Medicine. 28(11). e18365–e18365. 4 indexed citations
4.
Zhang, Chi, et al.. (2024). Reasons and experience for patients with amyotrophic lateral sclerosis using traditional Chinese medicine: a CARE-TCM based mixed method study. BMC Complementary Medicine and Therapies. 24(1). 231–231. 1 indexed citations
5.
Lin, Miao, Yanyan Liu, Honglin Chen, et al.. (2023). Atherosclerosis-related biomarker PABPC1 predicts pan-cancer events. Stroke and Vascular Neurology. 9(2). 108–125. 5 indexed citations
6.
Wang, Ying, et al.. (2023). Association of plasma sPD‐1 and sPD‐L1 with disease status and future relapse in AQP4‐IgG (+) NMOSD. Annals of Clinical and Translational Neurology. 11(2). 436–449.
7.
Ito, Masaaki, Takaki Hiwasa, Satoshi Yajima, et al.. (2022). Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma. Esophagus. 19(4). 617–625. 4 indexed citations
8.
9.
Sugimoto, Kazuo, et al.. (2022). Herbal medicine for amyotrophic lateral sclerosis: A systematic review and meta-analysis. Frontiers in Pharmacology. 13. 946548–946548. 7 indexed citations
10.
11.
Sugimoto, Kazuo, Masahiro Mori, Jia Liu, et al.. (2021). Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 22(5-6). 388–394. 11 indexed citations
12.
Asseyer, Susanna, Hiroki Masuda, Masahiro Mori, et al.. (2021). AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(2). 3080370062–3080370062. 6 indexed citations
13.
Sugimoto, Kazuo, et al.. (2021). Neuroprotective Effects of Shenqi Fuzheng Injection in a Transgenic SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis. Frontiers in Pharmacology. 12. 10 indexed citations
14.
15.
Zhang, Jielin, et al.. (2021). Antidepressant-Like Effect of Geniposide in Mice Exposed to a Chronic Mild Stress Involves the microRNA-298-5p-Mediated Nox1. Frontiers in Molecular Neuroscience. 13. 131–131. 25 indexed citations
16.
Sugimoto, Kazuo, et al.. (2020). Correlational Analysis of ALS Progression and Serum NfL Measured by Simoa Assay in Chinese Patients. Frontiers in Neurology. 11. 579094–579094. 17 indexed citations
17.
Liu, Jia, Masahiro Mori, Kazuo Sugimoto, et al.. (2019). Peripheral blood helper T cell profiles and their clinical relevance in MOG-IgG-associated and AQP4-IgG-associated disorders and MS. Journal of Neurology Neurosurgery & Psychiatry. 91(2). 132–139. 21 indexed citations
18.
Sugimoto, Kazuo, Takaki Hiwasa, Shigeki Hirano, et al.. (2018). Novel autoantibodies against the proteasome subunit PSMA7 in amyotrophic lateral sclerosis. Journal of Neuroimmunology. 325. 54–60. 10 indexed citations
19.
Muto, Mayumi, Masahiro Mori, Takaki Hiwasa, et al.. (2015). Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies. Journal of Neuroimmunology. 284. 30–36. 16 indexed citations
20.
Wang, Lu, Jan Valentini, Kazuo Sugimoto, et al.. (2011). Biomedical Teleacupuncture between China and Austria Using Heart Rate Variability, Part 1: Poststroke Patients. Evidence-based Complementary and Alternative Medicine. 2011(1). 782489–782489. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruxiang Xu Breakdown of academic impact, for papers by Adrian Bălașa Breakdown of academic impact, for papers by Chong-Un Cheong Breakdown of academic impact, for papers by Fang Cui Breakdown of academic impact, for papers by Suning Ping Breakdown of academic impact, for papers by Makoto Hayase Breakdown of academic impact, for papers by Hsu‐Tung Lee Breakdown of academic impact, for papers by Jishu Xian
Rankless by CCL
2026